Antibiotic resistance of Campylobacter jejuni and Campylobacter coli clinical isolates from Poland.
We tested 102 Campylobacter jejuni and 6 Campylobacter coli clinical isolates from Poland. All were susceptible to erythromycin. Among the tested C. jejuni isolates 55.9% and 13.7% were resistant to ciprofloxacin and tetracycline, respectively. Replacement of Thr86 with Ile in GyrA and a plasmid-borne tet(O) gene were the main resistance mechanisms for fluoroquinolones and tetracycline, respectively.
Wardak
Sebastian
S
National Institute of Hygiene, Department of Bacteriology, 24 Chocimska Street, 00-791 Warsaw, Poland. swardak@pzh.gov.pl
Szych
Jolanta
J
Zasada
Aleksandra Anna
AA
Gierczynski
Rafal
R
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002169:Campylobacter Infections / Q000382:microbiology; D017000:Campylobacter coli / Q000187:drug effects*; D016123:Campylobacter jejuni / Q000187:drug effects*; D027081:DNA Gyrase / Q000235:genetics; D004269:DNA, Bacterial / Q000235:genetics; D024881:Drug Resistance, Bacterial; D004591:Electrophoresis, Polyacrylamide Gel; D005243:Feces / Q000382:microbiology; D006801:Humans; D008826:Microbial Sensitivity Tests; D010957:Plasmids / Q000235:genetics; D011044:Poland; D012150:Polymorphism, Restriction Fragment Length; D013753:Tetracycline Resistance
D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D027081:DNA Gyrase